uniQure (QURE) Capital Expenditures (2016 - 2026)
uniQure's (QURE) quarterly Capital Expenditures came in at $140000.0 in Q1 2026, up 11.11% year-on-year from $126000.0 in Q1 2025, and up 17.65% quarter-over-quarter from $119000.0 in Q4 2025.
uniQure (QURE) Capital Expenditures (2016 - 2026) Analysis & Trends
uniQure's Capital Expenditures history runs 11 years deep, the most recent figure standing at $140000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 11.11% year-over-year to $140000.0 in Q1 2026; TTM through Mar 2026 was $453000.0, a 60.61% decrease from a year earlier, with the FY2025 full-year figure at $439000.0, down 86.97% from the prior year.
- Capital Expenditures climbed to $140000.0 in Q1 2026 per QURE's latest filing, from $119000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $5.1 million in Q4 2022 and bottomed at -$66000.0 in Q3 2025.
- The 5-year median for Capital Expenditures is $1.1 million (2023), against an average of $1.7 million.
- Biggest YoY gain for Capital Expenditures was 197.5% in 2025; the steepest drop was 117.37% in 2025.
- Year by year, Capital Expenditures stood at $5.1 million in 2022, then tumbled by 59.77% to $2.0 million in 2023, then plunged by 98.04% to $40000.0 in 2024, then soared by 197.5% to $119000.0 in 2025, then rose by 17.65% to $140000.0 in 2026.
- Per Business Quant, the three latest QURE Capital Expenditures figures stand at $140000.0 (Q1 2026), $119000.0 (Q4 2025), and -$66000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | 140,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 140,000.00 |
| Mar 31, 2026 | 140,000.00 |
| Dec 31, 2025 | 119,000.00 |
| Dec 31, 2025 | 119,000.00 |
| Sep 30, 2025 | -66,000.00 |
| Sep 30, 2025 | -66,000.00 |
| Jun 30, 2025 | 260,000.00 |
| Jun 30, 2025 | 260,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 380,000.00 |
| Sep 30, 2024 | 380,000.00 |
| Jun 30, 2024 | 604,000.00 |
| Jun 30, 2024 | 604,000.00 |
| Mar 31, 2024 | 2.34 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Dec 31, 2023 | 2.04 Mn |